Multicenter early United States feasibility study and periprocedural safety of LVIS EVO for the treatment of unruptured intracranial aneurysms
Kayan Y, Almandoz J, Copelan A, Matouk C, Chaudry M, Altschul D, Essibayi M, Goren O, Yim B, Tsappidi S, Zhang Y, Hui F, Samaniego E, Gudino A, Siddiqui A, Jaikumar V, Puri A, Kühn A, Singh J, Ringer A, Hanel R, De Toledo O, Dabus G, Gooch M, Sizdahkhani S, Field N, Paul A. Multicenter early United States feasibility study and periprocedural safety of LVIS EVO for the treatment of unruptured intracranial aneurysms. Journal Of NeuroInterventional Surgery 2024, 17: jnis-2024-021900. PMID: 38906689, DOI: 10.1136/jnis-2024-021900.Peer-Reviewed Original ResearchConceptsLow-profile visualized intraluminal supportIntracranial aneurysmsHemorrhagic complicationsTreatment of unruptured intracranial aneurysmsComplete neck coverageAverage aneurysm sizeInstitutional review board approvalClass I occlusionReview board approvalAnterior communicating arteryTreatment of intracranial aneurysmsMiddle cerebral artery bifurcationUnruptured intracranial aneurysmsSelf-expanding stentsCerebral artery bifurcationLength of stayParent vessel sizePatient agePeriprocedural complicationsPeriprocedural safetyAneurysm locationAneurysm sizeAntiplatelet therapyBoard approvalIntraluminal support
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply